This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Global Cardiac Medical Devices - An Analytical Report, 2009-2015

Interventional Cardiac Devices (ICD)1. Coronary Stents2. PTCA Balloons3. Cardiac Catheters4. Intravascular Ultrasound Catheters (IVUS)5. Coronary Guidewires6. Arteriotomy Closure Devices &7. Introducer Sheaths and Others

Cardiac Monitoring and Diagnostic Devices (CM&D)1. Electrocardiography Devices (ECG)2. Event Monitors (Manual and Automatic)3. Cardiac Stimulating Devices4. Remote Cardiac Monitors5. Holter Monitors6. Others (Wrist Rate Monitors, Strapped Rate Monitors)

Peripheral Vascular Devices (PVD)1. Peripheral Vascular Stents2. PTA Balloon Catheters3. Aortic Stent Graft4. Inferior Vena Cava (IVC) Filters5. Embolic Protection Devices (EPD)6. Peripheral Guidewires7. Synthetic Surgical Grafts8. Others

Electrophysiology (EP) Devices1. Diagnostic Electrophysiology Catheters2. EP Laboratory Devices3. EP Ablation Catheters4. Others

Cardiac Prosthetic Devices (CPD)1. Mechanical Heart Valves2. Tissue Heart Valves &3. Transcatheter Heart Valves

The period considered for the study analysis is 2009-2015. The region wise distribution of the market consists of North America ( USA and Canada), Europe ( United Kingdom, Germany, France, Italy, Spain, Russia, Belgium and Rest of Europe), Asia-Pacific ( Japan, China, India, New Zealand, South Korea, Australia and Rest of Asia-Pacific), Latin America ( Brazil, Argentina and Rest of Latin America) and Rest of World ( South Africa, Middle East and Rest of Rest of World). Incorporating the recession impacts on the industry, the market growth rate in the major economies such as the U.S., Japan, China etc. are estimated individually for the upcoming years.More than 700 leading market players are identified and 95 key companies in cardiac medical devices industry that project improved market activities in the near future are profiled. The report consists of 617 data charts describing the market shares, sales forecasts and growth prospects. Moreover, key strategic activities in the market including mergers/acquisitions, collaborations/partnerships, product launches/developments are discussed.Estimates are based on online surveys using customized questionnaires by our research team. Besides information from government databases, company websites, press releases & published research reports are also used for estimates. Estimates have incorporated recessionary impact on the cardiac devices industry.


2 of 6

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free


Chart of I:DJI
DOW 16,472.37 +200.36 1.23%
S&P 500 1,951.36 +27.54 1.43%
NASDAQ 4,707.7750 +80.6910 1.74%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs